No Data
J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab
European stock markets are expected to close at record highs for the first time since May.
European stock markets are reclaiming lost ground from the summer and are expected to close at record highs for the first time since May, as strong economic data eases concerns about U.S. recession and investors bet on a Fed rate cut. The benchmark Stoxx Europe 600 index briefly rose 0.8% to 524.75 points, above the May closing high of 524.71 points, still below the intraday high of 525.59 reached in June. Danish pharmaceutical company Novo Nordisk, Dutch chip equipment company ASML, German software company SAP, and British pharmaceutical company AstraZeneca contributed to over a quarter of the index's gains this year. Danish pharmaceutical company Zealand.
New Medicare Drug Price Caps Could Help Seniors Save Over $1,000 a Year - AARP
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical
Research has found that SGLT2 inhibitors, a type of antidiabetic medication, can help prevent dementia.
According to a new study, certain types of drugs used to treat type 2 diabetes may help prevent certain cases of dementia.
QIAGEN Expands Master Collaboration Agreement With AstraZeneca's Future Therapies To Develop And Validate A Genotyping Assay Using Co's Syndromic Testing Platform QIAstat-Dx
No Data
not 50B. Point is that Roche would be dummies to screw us over
Green Dragon 2024 : That makes total sense. Especially, when Tom Lee stated that there should be a 40% growth in the small caps (Russell). Great information thank you!